Skip to main content

Best Performing Stocks Year-to-Date

100 stocks · Updated Aug 8, 2026

Year-to-date performance leaders reflect the stocks generating the most price appreciation since January 1st of the current year. Leading performers include companies reporting earnings beats, receiving regulatory approvals, executing strategic pivots, or simply benefiting from sector momentum. YTD leaders are a useful starting point for momentum research, though historical outperformance does not guarantee future returns and many YTD leaders mean-revert by year end.

StockPriceYTDMarket Cap
AKTSAktis Oncology, Inc.$24.30+65209.10%$1.23B
BKNGBooking Holdings Inc.$214.30+2401.02%$149.47B
LIFEEthos Technologies Inc.$31.56+1561.05%$1.28B
AGLAgilon Health, Inc.$97.82+468.06%$1.53B
AXTIAXT, Inc.$88.21+439.51%$3.48B
ROMARoma Green Finance Limited Ordinary Shares$8.90+426.63%$587.9M
RXTRackspace Technology, Inc.$4.97+411.90%$1.05B
SNDKSandisk Corporation$1212.62+410.83%$179.90B
AEHRAehr Test Systems$102.26+406.49%$3.22B
ERASErasca, Inc.$18.30+391.94%$6.38B
ATEXAnterix Inc.$98.09+349.36%$1.96B
MXLMaxLinear, Inc.$75.13+331.04%$6.60B
EVCEntravision Communications$12.04+310.75%$1.03B
BLZEBackblaze, Inc.$18.83+304.08%$823.4M
ELVNEnliven Therapeutics, Inc.$60.60+293.51%$4.26B
AAOIApplied Optoelectronics, Inc.$135.60+288.98%$10.56B
IBRXImmunityBio, Inc.$7.58+282.58%$7.28B
ICHRIchor Holdings, Ltd.$68.30+270.59%$2.29B
TWSTTwist Bioscience Corporation$116.33+266.74%$6.19B
DELLDell Technologies Inc.$452.67+259.60%$269.19B
DDDuPont de Nemours, Inc.$142.21+253.76%$19.08B
MAASMaase Inc.$18.96+251.11%$6.26B
CLYMClimb Bio, Inc.$13.92+248.00%$811.4M
UCTTUltra Clean Holdings, Inc.$87.22+244.31%$3.73B
DFTXDefinium Therapeutics, Inc.$45.62+240.70%$4.62B
MQMarqeta, Inc.$16.09+238.84%$1.63B
BANDBandwidth Inc.$50.72+228.28%$1.19B
ORKAOruka Therapeutics, Inc.$98.69+225.60%$5.86B
SYRESpyre Therapeutics, Inc.$104.67+219.49%$8.98B
CORTCorcept Therapeutics Incorporated$109.84+215.63%$11.87B
SLSSELLAS Life Sciences Group, Inc.$11.86+214.59%$1.86B
TXG10x Genomics, Inc.$50.69+210.79%$5.79B
MUMicron Technology, Inc.$873.54+206.06%$929.52B
PLSEPulse Biosciences, Inc.$41.78+204.30%$2.65B
TNGXTango Therapeutics, Inc.$26.93+203.95%$3.58B
PENGPenguin Solutions, Inc.$58.63+199.72%$2.86B
STXSeagate Technology Holdings plc$817.25+196.76%$191.97B
IRDMIridium Communications Inc.$49.69+185.90%$5.26B
APPSDigital Turbine, Inc.$14.17+183.40%$974.7M
ALMSAlumis Inc.$27.60+182.79%$3.43B
FBRXForte Biosciences, Inc.$76.78+181.56%$1.58B
SIMOSilicon Motion Technology Corporation$255.67+175.80%$4.08B
KOSKosmos Energy Ltd.$2.50+174.96%$1.24B
FCELFuelCell Energy, Inc.$20.04+174.08%$1.14B
INTCIntel Corp.$100.82+173.22%$454.97B
KELYBKelly Services, Inc.$23.46+169.50%$500.1M
ETONEton Pharmaceuticals, Inc.$45.12+166.79%$1.27B
DRTSAlpha Tau Medical Ltd$13.15+165.66%$1.06B
CDNLCardinal Infrastructure Group Inc.$64.03+164.81%$946.5M
DNTHDianthus Therapeutics, Inc.$108.22+162.62%$4.59B
Showing 1-50 of 100 stocks

Get Your Daily Market Recap

TickFlow Daily delivers the top gainers, losers, and signals to your inbox every day at market close. Free.

Frequently Asked Questions

Is YTD performance a good predictor of future returns?

Momentum research shows short-term (1-12 month) performance does have some predictive value over the following 1-6 months. However, many YTD leaders experience mean reversion. Past YTD performance is a useful screening input, not a buy signal on its own.

What typically drives the top YTD performers?

Earnings beats, product launches, M&A activity, regulatory approvals (especially in healthcare and cannabis), short squeezes, sector rotations, and macro tailwinds are the most common catalysts for outperformance in any given year.

Should I buy YTD leaders to follow momentum?

Momentum strategies can work but require strict rules around position sizing and exit triggers. Chasing YTD leaders without understanding the fundamental catalyst often means buying after the easy gain is already captured.

How does this list change over time?

This list resets at January 1 each year. Early in the year, even small gains land stocks on the list. By year-end, the list reflects the genuine full-year outperformers. The composition changes significantly as the year progresses.

Related Stock Lists